Science to Society: Anthrax and DNA Replication

1. Background on Anthrax

Bacillus anthracis is a bacterium that causes anthrax, a serious infectious disease. Anthrax spores are highly resilient, surviving for decades in harsh conditions. The disease is significant in both medical and security contexts due to its potential use as a bioterrorism agent.

• Cutaneous anthrax: Causes black, necrotic skin lesions.

• Gastrointestinal anthrax: Leads to severe digestive illness.

• Inhalation anthrax: The deadliest form, can cause respiratory distress, sepsis, and death if untreated.

Anthrax as a biothreat: Its resilience and lethality make it a concern for public health and security.

2. DNA Replication and Antibiotic Targeting

Anthrax bacteria replicate by copying their DNA. Antibiotics can target this process to inhibit bacterial growth.

• DNA gyrase (a type II topoisomerase): Relieves supercoiling during DNA replication.

• Topoisomerase IV: Separates newly replicated chromosomes.

• Both enzymes are essential for bacterial survival. Inhibiting them halts DNA replication and prevents bacterial growth.

Example: Ciprofloxacin is an antibiotic that targets DNA gyrase and topoisomerase IV in Bacillus anthracis.

3. Science Core

Understanding the molecular targets of antibiotics helps in designing effective treatments and combating antibiotic resistance.

• Antibiotic specificity: Some antibiotics, like penicillin, target bacterial cell wall synthesis, while others target DNA replication enzymes.

• Comparison: Bacterial DNA replication differs from human DNA replication, allowing selective targeting by antibiotics.

4. Science-to-Society Links

Decisions about antibiotic use have broad societal implications, including public health policy and the risk of antibiotic resistance.

• Example: In 2001, ciprofloxacin was distributed widely as a precaution against anthrax exposure.

• Considerations: Public officials must weigh the benefits and risks of mass antibiotic distribution, including potential side effects and the development of resistant bacteria.

Case Study: Telomerase, DNA Structure, and Human Health

Part A: DNA Structure Refresher

DNA is composed of a sugar-phosphate backbone, nitrogenous bases, and forms a double helix structure.

• Telomeres: The ends of linear chromosomes, consisting of repetitive DNA sequences (e.g., TTAGGG in humans), protect chromosomes from deterioration.

Part B: Telomerase Function

Telomerase is an enzyme that adds DNA repeats to telomeres, counteracting their shortening during DNA replication.

• Role in replication: Telomerase solves the "end-replication problem" by extending telomeres.

• Cell types with telomerase activity: Germ cells, stem cells, and cancer cells.

• Somatic cells: Most do not express telomerase, leading to gradual telomere shortening and limited lifespan.

Part C: Medical Applications

Manipulating telomerase activity has potential applications in aging and cancer therapy.

• Potential benefits: Delayed aging, improved cell renewal.

• Risks: Uncontrolled cell growth (cancer) due to immortalized cells.

• Therapeutic design: Balancing the benefits of telomerase activation with the risk of promoting cancer is a key challenge.

Part D: Ethical and Societal Reflections

Access to anti-aging therapies and telomerase-based treatments raises ethical and social questions.

• Equity: Who should have access to such treatments—only the elderly, or all age groups?

• Societal impact: Unequal access could exacerbate health disparities.

• Medical vs. enhancement use: Should telomerase activation be used for anti-aging in healthy individuals?

DNA Analysis: PCR, Restriction Enzymes, and Gel Electrophoresis

1. DNA Sequence Analysis

Comparing normal and abnormal DNA sequences can reveal mutations associated with diseases (e.g., sickle cell anemia).

• Mutation identification: Sequence comparison highlights base changes responsible for disease.

2. Polymerase Chain Reaction (PCR)

PCR is a technique used to amplify specific DNA regions.

• Primers: Short DNA sequences that bind to target regions, enabling selective amplification.

• Amplification: Each PCR cycle doubles the DNA amount. After n cycles, the number of copies is .

3. Restriction Enzyme Digestion

Restriction enzymes cut DNA at specific sequences. Mutations can create or abolish restriction sites, altering fragment patterns.

• Example: Mst II recognizes CCTGAGG. A mutation can abolish this site, as in sickle cell disease.

4. Gel Electrophoresis

DNA fragments are separated by size using an electric field in a gel matrix.

• Smaller fragments move faster and farther than larger ones.

• Visualization: Bands represent DNA fragments of different sizes.

Example Table: DNA Fragment Sizes in Gel Electrophoresis

Additional info: Table entries inferred for illustration; actual fragment sizes depend on specific restriction sites and mutations.

5. Inheritance and Genetic Analysis

Each person inherits two copies of each gene, one from each parent. Comparing DNA fragment patterns can determine inheritance and identify genetic diseases.

• Alleles: Different versions of a gene.

• Genetic testing: Used for disease diagnosis, carrier detection, and paternity testing.

6. Communicating Results

Explaining genetic test results to non-experts requires clear communication, emphasizing the meaning of bands, inheritance patterns, and implications for health.

Key Terms and Concepts

• Anthrax: Infectious disease caused by Bacillus anthracis.

• DNA gyrase/Topoisomerase: Enzymes involved in DNA replication.

• Telomere: Repetitive DNA at chromosome ends.

• Telomerase: Enzyme that extends telomeres.

• PCR (Polymerase Chain Reaction): Technique to amplify DNA.

• Restriction enzyme: Protein that cuts DNA at specific sequences.

• Gel electrophoresis: Technique to separate DNA fragments by size.